Ekso Bionics Holdings Inc
(EKSO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,617 | -6,551 | -26,992 | -22,860 | -15,877 |
| Depreciation Amortization | 548 | 276 | 1,667 | 1,293 | 972 |
| Accounts receivable | -931 | -188 | -850 | -109 | -678 |
| Accounts payable and accrued liabilities | -654 | -660 | 752 | 1,058 | 210 |
| Other Working Capital | -1,391 | -1,198 | 530 | 1,560 | 890 |
| Other Operating Activity | 2,337 | 3,144 | 2,728 | 2,047 | 1,679 |
| Operating Cash Flow | $-9,708 | $-5,177 | $-22,165 | $-17,011 | $-12,804 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -60 | -7 | -131 | -51 | -31 |
| Investing Cash Flow | $-60 | $-7 | $-131 | $-51 | $-31 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,185 | -591 | -2,174 | -1,585 | -994 |
| Common Stock Issued | 16,553 | 7,360 | 4,447 | 3,962 | N/A |
| Financing Cash Flow | $15,368 | $6,769 | $2,273 | $2,377 | $-994 |
| Exchange Rate Effect | 7 | -4 | -135 | -133 | -94 |
| Beginning Cash Position | 7,655 | 7,655 | 27,813 | 27,813 | 27,813 |
| End Cash Position | 13,262 | 9,236 | 7,655 | 12,995 | 13,890 |
| Net Cash Flow | $5,607 | $1,581 | $-20,158 | $-14,818 | $-13,923 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,708 | -5,177 | -22,165 | -17,011 | -12,804 |
| Capital Expenditure | -60 | -7 | -131 | -51 | -31 |
| Free Cash Flow | -9,768 | -5,184 | -22,296 | -17,062 | -12,835 |